Citadel Advisors - ALTAMIRA THERAPEUTICS LTD ownership

ALTAMIRA THERAPEUTICS LTD's ticker is and the CUSIP is G0360L209. A total of 10 filers reported holding ALTAMIRA THERAPEUTICS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ALTAMIRA THERAPEUTICS LTD
ValueSharesWeighting
Q3 2023$9,447
-79.8%
39,165
-46.3%
0.00%
Q2 2023$46,74972,9310.00%
Other shareholders
ALTAMIRA THERAPEUTICS LTD shareholders Q3 2023
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 829,000$202,6910.00%
Cutler Group LLC / CA 10$00.00%
Stonebridge Capital Advisors LLC 5$10.00%
WELLS FARGO & COMPANY/MN 25$60.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 298$720.00%
MORGAN STANLEY 500$1220.00%
Citadel Advisors 39,165$9,4470.00%
XTX Topco Ltd 10,131$2,4440.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 10,185$2,4570.00%
View complete list of ALTAMIRA THERAPEUTICS LTD shareholders